NetworkNewsBreaks Archive - Page 1109 of 2081

TuesdayMar 23, 2021 9:57 am

NetworkNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) Announces Initial Rollout of TAAT Via CROSSMARK

TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) has moved up to the highest tier of the OTC market. The company confirmed Tuesday that it has been officially upgraded from OTCQB(R) Venture Market (“OTCQB”) to the OTCQX(R) Best Market (“OTCQX”). The OTC Markets Group is the operator of financial markets for 11,000 U.S. and global securities. The OTCQX market is for established firms and is held to more stringent reporting and disclosure standards; companies on this market also require a professional third-party sponsor introduction. The OTCQB market is primarily for early-stage companies. In the announcement, TAAT noted that the…

MondayMar 22, 2021 3:40 pm

NetworkNewsBreaks – Darrow Associates Inc.’s Managing Director to Lead Small Cap Investment Panel at Investor Summit

Darrow Associates, a leading national investor relations (“IR”) consultancy, today announced that its Managing Director, Peter Seltzberg, will be leading a panel discussion on small cap investing at the Investor Summit conference. The event will be held virtually from March 23-25, 2021. According to the update, the topic of the 30-minute panel discussion, to be streamed online for conference participants at 12:30 p.m. ET on March 23, 2021, is “Small Cap Stocks in 2020-2021: Don’t Say They Aren’t Performing.” Seltzberg organized and conducted the panel, which consists of three investment professionals who identified the top performing shares in an informal…

MondayMar 22, 2021 2:07 pm

NetworkNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Looks Poised to Benefit from Growing Demand for CBD

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), an innovative genetics-based cannabis company located in Canada, appears to be positioned for opportunity driven by the growing demand for cannabidiol (“CBD”) due to a variety of factors. According to an article on Pac Roots, the first reason is that the company “leverages genetic technology to cultivate unique strains prized in the industry for their potency and overall effectiveness.” Secondly, “CBD continues to gain mainstream attention among health care professionals and the general public as a way to address symptoms of chronic diseases — particularly those associated with inflammation.” According to researchers…

MondayMar 22, 2021 1:53 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Conference Call to Discuss Q4 Numbers, Clinical Pipeline Update

Processa Pharmaceuticals Inc. (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, has scheduled a conference call to discuss its fourth-quarter financial report as well as to provide a drug-development update. The conference call and life webcast will be available to any participants dialing or logging in. Interested parties can dial 877-545-0320 in the United States or 973-528-0016 for international calls; the entry code is the same for both: 805295. A replay of the call will be available as well. To access that, interested parties can…

MondayMar 22, 2021 1:22 pm

NetworkNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Presents Data Regarding Drug Candidate for Replacement of Addictive Benzodiazepines

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new-generation medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, presented data highlighting the proposed mechanism of action (“MOA”) of its Phase 3 investigational drug candidate, PH94B nasal spray, in a poster session at the Anxiety and Depression Association of America’s 2021 Virtual Annual Conference. VTGN’s PH94B spray is designed to provide rapid-onset acute treatment of anxiety without directly activating gamma-amino butyric acid (“GABA-A”) receptors. This approach differentiates PH94B from benzodiazepines such as alprazolam, diazepam and lorazepam, which are…

MondayMar 22, 2021 12:53 pm

NetworkNewsBreaks – Trident Acquisitions Corp. (NASDAQ: TDAC) Files Current Report on Form 8-K to Reflect Pending Lottery.com Acquisitions

Trident Acquisitions (NASDAQ: TDAC, TDACU, TDACW), a special purpose acquisition company, previously announced its entry into a definitive agreement with AutoLotto Inc., a leading online platform to play the lottery online. The agreement allows Lottery.com to become a publicly listed company. Today, Lottery.com announced its entry into a binding agreement to acquire Mexican lottery companies JuegaLotto and Aganar to expand its operations to Mexico and throughout Latin America. In anticipation of Lottery.com completing the acquisitions before completion of the business combination, Trident filed a current report on Form 8-K with the U.S. Securities and Exchange Commission (“SEC”), which is available…

MondayMar 22, 2021 12:10 pm

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces 2020 Results and Transformative Year, to Host Webcast on March 23, 2021

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, today reported its financial results for the year-ended December 31, 2020. The company also announced that it will host a video webcast at 4:00 p.m. ET (2:00 p.m. MT) on Tuesday, March 23, 2021, to discuss its 2020 financial results and other corporate initiatives. Interested parties should visit https://nnw.fm/VOXOD to register for and join the webcast and to access the presentation and viewer-controlled webcast slides. "2020 was a transformative year for Energy Fuels, as we worked on developing a rare earth business complementary to our core uranium…

MondayMar 22, 2021 11:08 am

NetworkNewsBreaks – Asia Broadband Inc. (AABB) Launches Sales of Gold-Backed Cryptocurrency Token

Asia Broadband (OTC: AABB) announced the sales launch of its AABB Gold (“AABBG”) cryptocurrency token. The token was developed by Core State Holdings Corp. (“CSHC”). The announcement noted that AABB Wallet users who want to purchase the new tokens must update the AABB Wallet app or install the latest version of the app as well as pass the Know Your Client (“KYC”) process. Because the new token will only be available for purchase in exchange for other major cryptocurrencies including Bitcoin, Ethereum and Litecoin, those wanting to purchase AABB Gold token will need to own cryptocurrency in a third-party wallet. To…

MondayMar 22, 2021 10:57 am

NetworkNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Secures $30.5M in Registered Direct Offering

Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, has closed its previously announced offering of an aggregate of 10,000,000 shares of common stock of the company. Per an update released today, Uranium Energy secured gross proceeds of $30,500,000 in the registered direct offering, with each of the shares sold at a purchase price of $3.05. The company offered and sold the shares per a securities purchase agreement, dated March 17, 2021, with certain institutional investors. UEC intends to use the net proceeds for additional uranium purchases and for general corporate and working capital purposes.…

MondayMar 22, 2021 10:47 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Enters Strategic Drug Development Agreement with Catalent Inc. (NYSE: CTLT)

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced its entry into a drug development agreement with Catalent (NYSE: CTLT), the leading global provider of advanced delivery technologies, development and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. According to the update, Cybin will be applying Catalent’s proprietary Zydis(R) orally disintegrating tablet (“ODT”) technology for the delivery of its novel deuterated tryptamine (“CYB003”), a potential therapy for treatment-resistant psychiatric disorders. “We are excited to partner with the team at Catalent with the aim of developing fast-acting, shorter-duration formulations of…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks